OS Therapies
(NYSEMKT) OSTX
OS Therapies Financials at a Glance
Market Cap
$47.89M
Revenue (TTM)
$0.00
Net Income (TTM)
$28.75B
EPS (TTM)
$-0.94
P/E Ratio
-1.45
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Price
$1.36
Volume
353,442.66
Open
$1.37
Price
$1.36
Volume
353,442.66
Open
$1.37
Previous Close
$1.36
Daily Range
$1.35 - $1.43
52-Week Range
$1.12 - $2.57
Dividend
$0.00
Beta (Volatility)
1.57 (High)
Price
$1.36
Volume
353,442.66
Open
$1.37
Previous Close
$1.36
Daily Range
$1.35 - $1.43
52-Week Range
$1.12 - $2.57
OSTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OS Therapies
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Paul A. Romness
Website
www.ostherapies.comHeadquarters
Rockville, MD 21638, US
OSTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-914%
Return on Capital
5%
Return on Assets
-4%
Earnings Yield
-68.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$47.89M
Shares Outstanding
35.21M
Volume
353.44K
Short Interest
0.00%
Avg. Volume
572.39K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$28.71B
EBITDA
$28.71B
Operating Cash Flow
$14.24B
Capital Expenditure
$0.00
Free Cash Flow
$14.24B
Cash & ST Invst.
$269.83M
Total Debt
$0.00
OS Therapies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$238.15K
+17232.9%
Gross Margin
0.00%
N/A
Market Cap
$47.89M
N/A
Market Cap/Employee
$11.97M
N/A
Employees
4
N/A
Net Income
$28.74B
-960659.0%
EBITDA
$28.69B
-961936.0%
Quarterly Fundamentals
Net Cash
$269.83M
+4776.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-4.42%
N/A
Return on Invested Capital
5.46%
N/A
Free Cash Flow
$14.23B
-599062.9%
Operating Cash Flow
$14.23B
-599083.3%